Your browser doesn't support javascript.
loading
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma.
Bakouny, Ziad; Braun, David A; Shukla, Sachet A; Pan, Wenting; Gao, Xin; Hou, Yue; Flaifel, Abdallah; Tang, Stephen; Bosma-Moody, Alice; He, Meng Xiao; Vokes, Natalie; Nyman, Jackson; Xie, Wanling; Nassar, Amin H; Abou Alaiwi, Sarah; Flippot, Ronan; Bouchard, Gabrielle; Steinharter, John A; Nuzzo, Pier Vitale; Ficial, Miriam; Sant'Angelo, Miriam; Forman, Juliet; Berchuck, Jacob E; Dudani, Shaan; Bi, Kevin; Park, Jihye; Camp, Sabrina; Sticco-Ivins, Maura; Hirsch, Laure; Baca, Sylvan C; Wind-Rotolo, Megan; Ross-Macdonald, Petra; Sun, Maxine; Lee, Gwo-Shu Mary; Chang, Steven L; Wei, Xiao X; McGregor, Bradley A; Harshman, Lauren C; Genovese, Giannicola; Ellis, Leigh; Pomerantz, Mark; Hirsch, Michelle S; Freedman, Matthew L; Atkins, Michael B; Wu, Catherine J; Ho, Thai H; Linehan, W Marston; McDermott, David F; Heng, Daniel Y C; Viswanathan, Srinivas R.
Affiliation
  • Bakouny Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Braun DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Shukla SA; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Pan W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Gao X; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Hou Y; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Flaifel A; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Tang S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Bosma-Moody A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • He MX; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Vokes N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Nyman J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Xie W; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Nassar AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Abou Alaiwi S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Flippot R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Bouchard G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Steinharter JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Nuzzo PV; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Ficial M; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Sant'Angelo M; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Forman J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Berchuck JE; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Dudani S; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Bi K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Park J; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada.
  • Camp S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Sticco-Ivins M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Hirsch L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Baca SC; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Wind-Rotolo M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Ross-Macdonald P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Sun M; Bristol-Myers Squibb, Princeton, NJ, USA.
  • Lee GM; Bristol-Myers Squibb, Princeton, NJ, USA.
  • Chang SL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Wei XX; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • McGregor BA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Harshman LC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Genovese G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Ellis L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Pomerantz M; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hirsch MS; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Freedman ML; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Atkins MB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Wu CJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Ho TH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Linehan WM; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
  • McDermott DF; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Heng DYC; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Viswanathan SR; Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA.
Nat Commun ; 12(1): 808, 2021 02 05.
Article in En | MEDLINE | ID: mdl-33547292
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Carcinoma, Renal Cell / Gene Expression Regulation, Neoplastic / Rhabdoid Tumor / Antineoplastic Agents, Immunological / Immune Checkpoint Inhibitors / Immune Checkpoint Proteins / Kidney Neoplasms Type of study: Observational_studies / Risk_factors_studies Language: En Journal: Nat Commun Year: 2021 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Carcinoma, Renal Cell / Gene Expression Regulation, Neoplastic / Rhabdoid Tumor / Antineoplastic Agents, Immunological / Immune Checkpoint Inhibitors / Immune Checkpoint Proteins / Kidney Neoplasms Type of study: Observational_studies / Risk_factors_studies Language: En Journal: Nat Commun Year: 2021 Document type: Article